For Authors

Slovenian Veterinary Research (the Journal) publishes original articles, which report the results of original research in most areas of biomedicine. The journal also publishes review articles dealing with rapidly developing areas of biomedicine or which update understanding of classical fields of biomedicine, as well as case reports, shorter scientific contributions, letters to the editor, etc.; which have not been published or are under consideration for publication elsewhere. Only papers written in English can be considered. Manuscripts should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org). The Journal is published in both print and electronic formats and may be viewed online at http://www.slovetres.si/.

Authors must submit manuscript through the webpage of Slovenian Veterinary Research (www.slovetres.si). All manuscripts are subjected to both editorial review and review by independent referees, selected by the editorial board.

The editorial board will translate titles, summaries and keywords into Slovene language if authors are not native Slovene speakers.

Transparency policy

Using the covering letter authors must include:

1. Originality statement:

The authors must certify that the material submitted for publication has not been published except in abstract form, and is not being considered for publication elsewhere.

2. Ethical statement:

The Editorial Boards will not allow the publication of papers describing experimental procedures on living animals which may reasonably be presumed to have inflicted unnecessary pain or discomfort upon them. To be acceptable for publication, experiments on living vertebrates or Octopus vulgaris should conform to the European Union’s legislation and are in accordance with guidelines set by the Committee for Research and Ethical Issues of IASP [www.iasp-pain.org/AM/Template.cfm?Section=Animal_Research].

We require every research article submitted to the Journal to include a statement that the study obtained ethics approval (or a statement that it was not required), including the name of the ethics committee(s) or institutional review board(s), the number/ID of the approval(s), and a statement that participants gave informed consent before taking part. Similar information must be declared in the Material and methods section of the manuscript which should also include the following details about animal study design:

a. The number of experimental and control groups.
b. Any steps taken to minimise the effects of subjective bias when allocating animals to treatment (e.g. randomisation procedure) and when assessing results (e.g. if done, describe who was blinded and when).
c. The experimental unit (e.g. a single animal, group or cage of animals).
d. For each experiment and each experimental group, including controls, provide precise details of all procedures carried out. If anaesthesia was used, the anaesthetic dose, and duration of surgery must be provided, as well as information about any intra- and/or post-operative drugs (ie, drug, dose, and inter-dosing interval, if given more than once). If pain was caused, the authors have to explain clearly how it was managed.
e. Authors must provide details of the animals used, including species, strain, sex, developmental stage (e.g. mean or median age plus age range) and weight (e.g. mean or median weight plus weight range). Further relevant information such as the source of animals, international strain nomenclature, genetic modification status (e.g. knock-out or transgenic), genotype, health/immune status, drug or test naive, previous procedures, etc.

3. Conflict of interest statement:

Authors are required to disclose any potential conflict of interest such as consultancies, financial involvement, patent ownership, etc. Authors of research articles must disclose at the time of submission any financial arrangement they have with the company whose product features prominently in the submitted manuscript, or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, such information must be communicated to the reader.

4. Contribution of each author statement:

All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Contribution of each author must be declared in the covering letter. All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Contribution of each author must be included in the covering letter, which should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals produced by the International Committee of Medical Journal Editors (or Vancouver Group)

    Authorship credit should be based on

        substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
        drafting the article or revising it critically for important intellectual content; and
        final approval of the version to be published. Authors should meet conditions I., II., and III.

    When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship defined above. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. The Journal generally lists other members of the group in the Acknowledgments. The Journal indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript; it also lists the names of collaborators if they are listed in Acknowledgments.
    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
    Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.


Corresponding author is fully responsible that all required statements in the covering letter are true. Papers are accepted on the understanding that authors are prepared to make available to other investigators any unique reagents or cell lines used in the work reported.

Contributions should be written in English and normally should not exceed 12 pages (27 lines per page, approx. 75 characters per line). The text should be double spaced and the lines should be numbered on the left-hand side. The SI system of units and index notation should be used. All manuscript must be submitted through the webpage www.slovetres.si. All fields in English on the submission webpage must be filled except Slovenian abstract for foreigners (otherwise submission won’t be possible). At initial submission, manuscript should be uploaded as a single file (preferably in .doc(x) format) with figures and tables embedded into the text. Authors are required to provide names of three potential reviewers. The reviewers should not have conflict of interest: reviewers cannot be from the same institution as authors of the manuscript and reviewers cannot be collaborators (as evident by joint publications) in the last 2 years.  At least one of the suggested reviewers must be from a different country than authors of the manuscript.

The front page of the manuscript should begin with the title, followed by the name and surname of the author(s). In case of more than one author, authors' names should be separated by commas. The next line ('Addresses of authors:') should contain the authors' full names and addresses, Institution, street and number, postcode and city) after the colon. All given data should be separated by commas. The name, address and E-mail and/or phone number of the corresponding author should be written in the next line.

The Summary of 200-300 words should follow on the next page. Under 'Keywords:' (after the colon), keywords should be given. Individual words or word combinations should be separated by semicolons.

Scientific papers and papers which present the author's research and findings should also include the following obligatory headings assigned by the author to appropriate parts of the text: Introduction, Materials and methods, Results, Discussion, and References. Review articles should consist of an Introduction, sections logically titled according to the content, and References. Information on fund-providers and other matters important for the paper (e.g. technical assistance) should be provided under 'Acknowledgements', which should be placed before the references. Figure legends should follow the references. Case reports should present new information to the literature. The case report should be comprised of the title of the article (do not include “a case report”), abstract, key words, introduction (background), case presentation, discussion and conclusion. The rest of the article should follow general guidelines detailed elsewhere in the instructions.

Slovenian Veterinary Research does not provide free English language editing. Therefore, it is full responsibility of the authors to ensure that manuscripts are written in acceptable English language. Unacceptable English language could be the reason for rejection of the manuscript and such manuscripts won’t be considered for review process.  The authors from non-English speaking countries should ensure that their manuscripts are fully checked by professional English lectors, preferably native English speakers.  Alternatively, Slovenian Veterinary Research does provide English editing to the authors as a paid service. For information how to use this service and current pricing please contact as at email: slovetres@vf.uni-lj.si.

First manuscript submission should include all graphics, figures, graphs, diagrams and tables logically incorporated in the text document as a single document. Figures and tables should be referred using Arabic numerals (e.g. Table 1:, Figure 1:, etc.). The colon should be followed by the text or title.

All references cited in the text should appear in the References. They should be numbered in the text in the order in which they appear, marked with Arabic numerals placed in parenthesis. The first reference in the text should determine the number and order of the respective source in the References. If the author refers again to a source which has already been used in the text, he/she should cite the number of the source had when it was referred to for the first time.

Only works which have been published or are available to the public in any other way may be referred to. Unpublished data, unpublished lectures, personal communications and similar should be mentioned in the references or footnotes at the end of the page on which they appear. Sources in the References should be listed in the order in which they appear in the text. If the source referred to was written by six authors or less, all of them should be cited; in the case of seven or more authors, only the first three should be cited, followed by 'et al.'

Examples of references

1. Book:
Hawkins JD. Gene structure and expression. Cambridge: University Press, 1991: 16.

ECDC. Annual epidemiological report on communicable diseases in Europe 2010: surveillance report. Stockholm: European Centre for Disease Prevention and Control, 2010: 59-62.

2. Chapter or article in a book:
Baldessarini RJ. Dopamine receptors and clinical medicine. In: Neve KA, Neve RL, eds. The dopamine receptors. Totowa: Human Press, 1996: 475-98.

Bonneau M, Mourot J, Noblet J, Lefaucheur L, Bidanel JP. Tissue development in Meishan pigs: muscle and fat development and metabolism and growth regulation by somatotropic hormone. In: Molena M, Legault C, eds. INRA Chinese Pig Symposium. Toulouse, 1990. Jouy en Josas, France: INRA Publishing, 1990: 203–13.

3. Article in a journal or newspaper:
Fuji J, Otsu K, Zorzato F, et al. Identification of mutation in porcine ryanodine receptor asociated with malignant hyperthermia. Science 1991; 253: 448-51.

Dotson C, Roper S, Spector A. PLC 2-independent behavioral avoidance of prototypical bitter-tasting ligands. Chem Senses 2005; 30: 593-600.

4. Article in proceedings of a meeting or symposium:
Schnoebelen CS, Louveau I, Bonneau M. Developmental pattern of GH receptor in pig skeletal muscle. In: the 6th Zavrnik memorial meeting. Lipica: Veterinary Faculty 1995: 83-6.

Any errata should be submitted to the editor-in-chief in good time after publication so that they may be published in the next issue.